April 2, 2025
TOPLINE: A systematic review of randomized clinical trials (RCTs) on idiopathic inflammatory myopathies (IIMs) found that race was not appropriately reported in nearly half of the […]
April 1, 2025
Preliminary safety data from a French registry on combination therapy in immune-mediated inflammatory diseases (IMIDs) show a concerning rate of serious infections and illustrate the need […]
April 1, 2025
When patients with inflammatory arthritis develop an infection while taking immunomodulatory drugs, temporarily interrupting the therapy does not improve outcomes, according to results from one of […]
March 31, 2025
TOPLINE: Human leukocyte antigen B27 (HLA-B27) positivity was associated with higher odds of non-remission in patients with juvenile idiopathic arthritis (JIA) at 18 years after disease […]
March 27, 2025
For patients with rheumatoid arthritis, going to the doctor to discuss any ongoing symptoms or problems can be a hardship, especially if rheumatologists are scarce in […]
March 27, 2025
TOPLINE: The incidence of serious adverse events did not differ significantly between combo therapy and monotherapy in patients with immune-mediated inflammatory diseases. However, specific combinations such […]
March 25, 2025
Ageism in healthcare not only is frustrating and demoralizing for older patients but also negatively affects care. In rheumatology, patients with rheumatoid arthritis (RA) diagnosed later […]
March 24, 2025
TOPLINE: Belimumab combined with standard therapy demonstrated significant improvements in mucocutaneous symptoms in patients with systemic lupus erythematosus (SLE) compared with placebo with standard therapy, with […]
March 21, 2025
TOPLINE: Sustained clinical remission for at least 3 years in patients with systemic lupus erythematosus (SLE) and active lupus nephritis significantly reduced the probability of developing […]